#United States #New York #Select Medical #Soleno Therapeutics #XOMA Royalty

Investigating Fair Deals for Shareholders of SEM, XOMA, SLNO, and KORE

Halper Sadeh LLC, a law firm focused on investor rights, is currently examining several companies to determine if they are acting in the best interests of their shareholders. The firm’s inquiry centers around potential violations of federal securities laws and possible breaches of fiduciary duties that could affect the financial interests of investors. This investigation pertains to four companies: Select Medical Holdings Corporation (NYSE: SEM), XOMA Royalty Corporation (NASDAQ: XOMA), Soleno Therapeutics, Inc. (NASDAQ: SLNO), and KORE Group Holdings, Inc. (NYSE: KORE).

Companies Under Scrutiny

• - Select Medical Holdings Corporation (SEM) is reportedly undergoing a sale to a group led by its own executives and directors for a cash value of $16.50 per share. Shareholders of SEM may want to assess whether the deal is genuinely advantageous or whether they are being shortchanged.
• - XOMA Royalty Corporation is in the process of selling itself to Ligand Pharmaceuticals for $39.00 per share. Investors are encouraged to evaluate the implications of this transaction on their investments.
• - Soleno Therapeutics plans to sell to Neurocrine Biosciences for $53.00 per share in cash. Shareholders have the right to seek clarity regarding the deal’s structure and its overall fairness.
• - KORE Group Holdings is being sold to Searchlight Capital Partners, L.P. and Abry Partners for $9.25 per share. This potential sale raises questions about whether the price reflects the company’s true market potential.

Shareholder Rights and Options

Halper Sadeh LLC emphasizes the importance of shareholder rights when considering such transactions. Investors are often in a challenging position when significant changes occur within the companies they query. The law firm encourages all shareholders associated with the companies in question to reach out and explore their rights, options, and the possible legal recourse available to them. This assistance is offered without any upfront cost, ensuring that investors can seek help without financial risk.

Furthermore, the firm may advocate for increased consideration from the buyers or ensure that necessary disclosures are maintained to uphold shareholders’ interests during the sales process. In situations where shareholders feel undervalued or misinformed about their investments, Halper Sadeh LLC has been active in pursuing legal action that not only seeks to increase financial benefits for shareholders but also strives for the implementation of corporate governance reforms.

Conclusion

For shareholders of Select Medical, XOMA, Soleno, and KORE, the current climate presents an opportunity to reassess their positions and ensure that their investments are being treated with the fairness they deserve. By collaborating with legal experts such as Halper Sadeh LLC, they can make informed decisions and potentially rectify any injustices they might face. The law firm has a solid track record of recovering funds for defrauded investors and reforming corporate practices that harm shareholder value. If you are a shareholder in any of these companies, now may be the time to act.

For more information, feel free to contact Halper Sadeh LLC and discuss your situation without obligation. Their experienced team is dedicated to advocating for investors' rights and maximizing returns on their investments.